Zydus' injectable plant receives four USFDA observations

Zydus Lifesciences Limited reported on September 5, 2025, that its injectable manufacturing plant in Jarod, near Vadodara, Gujarat, underwent an inspection by the USFDA. The inspection, conducted from August 25 to September 5, 2025, concluded with four observations.

Crucially, the company noted that there were no data integrity-related observations identified during the inspection. Zydus Lifesciences stated its commitment to working closely with the USFDA to address the observations expeditiously.

This disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dhval N. Soni, company secretary and compliance officer, signed the announcement.